In recent years, there has been a dramatic increase in multi-drug resistance (MDR) amongst gram-negative pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting organisms. This has impacted the treatment of both hospital and community acquired infections. Therefore, accurate and reliable MIC determination is crucial for a successful antimicrobial therapy.
The routine MIC plate MICRONAUT-S Pseudomonas MIC provides an extended spectrum of standard and critical important backup antibiotics used for treatment of infections caused by multi-drug resistant non-fermenting pathogens. It enables MIC determination of antibiotics like piperacillin-tazobactam, ceftazidime-avibactam, ceftolozane-tazobactam, meropenem, tigecyclin and colistin in a single test run. MIC values are interpreted according to currently valid EUCAST breakpoints.
The MICRONAUT-S Pseudomonas MIC test plate offers a range of features and benefits relating to the phenotypic quantification of MIC values for critically important backup antibiotics used for treatment of bacterial infections caused by non-fermenting bacteria.
Please contact your local representative for availability in your country.
Not for sale in the USA.
As of January 2022, the Legal Manufacturer of all MICRONAUT products is Bruker Daltonics GmbH & Co. KG.